How it works
How Much Does Immunotherapy for prostate cancer Cost in Turkey?
Immunotherapy for prostate cancer in Turkey typically costs from $8,000 to $24,000. Final pricing depends on the specific drug protocol, clinic accreditation, and the patient's diagnostic requirements in major hubs like Istanbul or Ankara. In the US, similar treatments cost around $76,500 on average. Turkey offers savings of approximately 79%, providing access to advanced oncological care at a lower entry point.
- Specific drug therapy: Approximately 20-30% premium for specialized monoclonal antibodies compared to standard protocols.
- Hospital accreditation: JCI-accredited facilities in Istanbul often command 15-20% higher rates than non-accredited regional clinics.
- Diagnostic bundling: PSMA PET-CT scans and oncologist consultations are frequently bundled into initial screening packages.
- Location factors: Medical hubs like Istanbul and Ankara maintain higher pricing tiers than smaller Turkish cities.
Bookimed Expert Insight: Choosing a clinic with international ties offers US-standard care at Turkish prices. Anadolu Medical Center follows strict Johns Hopkins Medicine protocols and holds OECI accreditation. This ensures patients receive the same immunotherapy algorithms used in top American hospitals. For those seeking established expertise, Memorial Şişli Hospital was the first in Turkey to achieve JCI accreditation. It maintains a 5-star reputation for international patient coordination. These institutions provide a high-value alternative by combining global medical standards with local cost advantages.
| Turkey | Austria | Spain | |
|---|---|---|---|
| Immunotherapy for prostate cancer | from $8,000 | ≈ $9,500 | from $6,000 |
Discover the Best Immunotherapy for prostate cancer Clinics in Turkey: 20 Verified Options and Prices
Hisar Hospital Intercontinental
Mustafa Solak







Memorial Bahçelievler Hospital
Fazilet Oner Dincbas



Memorial Ataşehir Hospital
Kamil Yalçın Polat


VM Medical Park Pendik Hospital
Cemil Bilir


Estophia Hospital
Immunotherapy for prostate cancer Overview in Turkey
- Immunotherapy - from $2,500This therapy boosts the body"s natural defenses to fight diseases like cancer, bringing less side effects.
- Bacillus Calmette-Guérin (BCG) therapy - from $7,000This therapy, employing a TB vaccine, aids in bladder cancer treatment, through direct insertion into the bladder.
- Immunotherapy with Keytruda (Pembolizumab) - from $2,800The therapy is a treatment enhancing the body"s immune system to fight cancer, using a drug highly targeted and effective.
- Immunotherapy for prostate cancer - from $8,000This therapy boosts the body"s immune system to fight against prostate cancer, offering a targeted, typically well-tolerated treatment.
- Immunotherapy for lung cancer - from $8,000This therapy boosts your body"s natural defenses to fight lung cancer, using substances made by the body itself.
- Immunotherapy for breast cancer - from $8,000This therapy boosts your immune system to fight and eradicate breast cancer cells effectively.
- Immunotherapy for kidney cancer - from $8,000This therapy boosts the body"s natural defenses, often prolonging life in kidney cancer patients.
- Sarcoma Immunotherapy - from $8,900This therapy boosts the body"s immune system to fight cancerous tumors, offering promising, targeted treatment for sarcoma.
Day 1
- Arrive at the medical facility for check-in.
- Meet with the oncologist for a consultation.
- Undergo necessary blood tests.
Day 2
- Get results from the blood tests.
- Prepare for the Immunotherapy treatment.
Day 3
- Begin the Immunotherapy treatment.
- The process takes about 3 hours.
- No anesthesia is required for this procedure.
Day 4
- Post-treatment consultation with the oncologist.
- Stay in the clinic for observation.
Week 1
- Start of the recovery period.
- Regular follow-up with the oncologist.
- Start light physical activities.
Week 2
- Progress to moderate physical activities.
- Continue the regular follow-up with the oncologist.
Week 3
- Return to work and other daily activities.
- Follow-up with the oncologist for progress check.
Week 4
- Resume sports and other strenuous activities.
- Continue regular follow-up with the oncologist.
Please note that each patient"s experience with Immunotherapy for prostate cancer can vary. The above timeline provides a general guideline but individual cases may differ.
What patients like:
- Cost. The Immunotherapy for prostate cancer cost in Turkey ranges from $8,000 to $24,000. This comparatively cheaper cost attracts many patients globally.
- Doctor’s professionalism. Patients appreciate the high level of doctors' professionalism. Most of them have international certifications and memberships in professional organizations.
- Service level. Patients are generally satisfied with the high service level, including personalized care and state-of-the-art facilities.
- Immunotherapy for prostate cancer efficacy. The modern techniques used in Turkey often result in positive outcomes, making patients appreciate the effectiveness of the treatment.
- Logistics. Patients enjoy the easy logistics, with many clinics offering airport pickups and accommodation arrangements.
What patients don’t like:
- Language barrier. Some patients encounter language barriers, although most clinics offer translation services.
- Waiting time. Despite efficient services, patients sometimes complain about the long waiting times due to high demand.
- Distance. For some, the distance to travel to Turkey for treatment can be an inconvenience.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Trusted Doctors
View all Doctors
Bulent Karagoz
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.
- Authored over 40 research publications focusing on tumor biology and immunology.
- Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
- Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
- Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Prof. Sezer Sağlam
Prof. Sezer Sağlam focuses on medical oncology with extensive experience in immunotherapy for prostate cancer at Gayrettepe Florence Nightingale Hospital.
- Professor in Medical Oncology since 2016
- Fellowship-trained at Istanbul University Medical Faculty
- Member of ESMO, ASCO, and Turkish Medical Oncology Association
- Specializes in gastrointestinal oncology

Sinan Karaaslan
Dr. Sinan Karaaslan is an expert oncologist specializing in urogenital system cancers, including prostate cancer, at Anadolu Medical Center.
- 29 years of experience in medical oncology
- Specialized training at Istanbul University's Cerrahpaşa Medical School
- Member of the Turkish Medical Oncology Society
- Focuses on immunotherapy and targeted therapies

Mustafa Solak
Specializes in immunotherapy for prostate cancer with training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.
- Experienced in treating various cancers including prostate, breast, and lung
- Completed fellowship at prestigious Hacettepe University Cancer Institute
- Trained at The University of Texas MD Anderson Cancer Center
- Works at Hisar Hospital Intercontinental
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
FAQ about Immunotherapy for prostate cancer in Turkey
Is immunotherapy available for prostate cancer in Turkey?
Immunotherapy for prostate cancer is available in Turkey through JCI-accredited centers in Istanbul and Ankara. Specialized oncologists provide advanced treatments like pembrolizumab for MSI-high tumors and cellular therapies for metastatic cases. Major institutions like Anadolu Medical Center maintain collaborations with Johns Hopkins Medicine to provide these protocols.
- Treatment eligibility: Doctors require molecular profiling to identify MSI-high or dMMR genetic markers first.
- Available modalities: Protocols include immune checkpoint inhibitors, cancer vaccines, and combined hormone therapy approaches.
- Expert centers: Memorial Şişli and Hisar Hospital Intercontinental offer personalized immunotherapy via multidisciplinary boards.
- Cost profile: Treatment starts from $8,000, saving patients up to 79% versus US averages.
Bookimed Expert Insight: Anadolu Medical Center stands out for prostate cancer care because its oncology team, including Professor Bulent Karagoz, holds specific training from Oxford and Israel. Their 20-year experience in tumor immunology is rare, as many clinics only focus on standard chemotherapy rather than these specialized biological markers.
Patient Consensus: Patients emphasize that while these treatments feel experimental due to local regulatory timelines, they highly recommend retesting biopsies in Turkey to confirm if tumors will respond to specific immunotherapy drugs.
What are the common types of immunotherapy used?
Common immunotherapy types include immune checkpoint inhibitors like pembrolizumab, cancer vaccines such as sipuleucel-T, and monoclonal antibodies. These treatments stimulate the immune system to identify and destroy malignant cells. Leading Turkish oncology centers, including Anadolu Medical Center, follow Johns Hopkins Medicine protocols for administration.
- Checkpoint inhibitors: Block PD-1/PD-L1 proteins to release immune system brakes on cancer cells.
- Treatment vaccines: Use dendritic cells or sipuleucel-T to specifically target prostate tumor antigens.
- Monoclonal antibodies: Lab-made proteins that flag cancer cells for destruction by immune cells.
- T-cell therapy: Modifies patient T-cells to enhance their natural ability to fight tumors.
Bookimed Expert Insight: While basic immunotherapy starts at $2,500, specialized prostate vaccines like sipuleucel-T are often accessed through clinical trials at JCI-accredited hubs like Memorial Şişli. Patients save up to 79% compared to U.S. costs while receiving care from ESMO-certified professors with over 20 years of experience.
Patient Consensus: Patients often report that while common therapies like Keytruda are accessible, success varies, and tracking side effects like fatigue is crucial during the first 6 months. Many advise verifying trial status through official health directories before committing to expensive out-of-pocket treatments.
What is the success rate for immunotherapy in Turkey?
Immunotherapy success rates in Turkey reach 60% to 70% for advanced prostate cancer when using monoclonal antibodies. Effectiveness depends on biomarkers like MSI-high or PD-L1 status, with approximately 20% of advanced cases showing durable long-term responses. Turkish oncology centers follow Joint Commission International standards and global treatment protocols.
- Success markers: Disease control rates reach 76.7% for early-line immunotherapy treatments.
- Clinical effectiveness: Metastatic melanoma response rates align with U.S. standards at 37% to 50%.
- Advanced therapies: CAR T-cell therapy achieves 80% to 90% remission for specific blood cancers.
- Strategic partnerships: Anadolu Medical Center maintains a formal affiliation with Johns Hopkins Medicine International.
Bookimed Expert Insight: Data suggests that the most successful outcomes involve specific tumor sequencing before traveling. While prostate cancer immunotherapy costs $8,000 to $24,000 here, only about 10% to 20% of patients typically qualify based on MSI or PD-L1 markers. Confirming these results first ensures you select a clinic like Anadolu Medical Center or Hisar Hospital Intercontinental that specializes in your specific tumor biology.
Patient Consensus: Patients report stable disease progression for over 6 months using pembrolizumab cycles. Many highlight a less rushed infusion experience compared to domestic clinics, though they emphasize the need to plan for multiple travel dates for recurring treatments.
What are the best hospitals for prostate-cancer immunotherapy in Turkey?
The best hospitals for prostate cancer immunotherapy in Turkey include Anadolu Medical Center, Memorial Şişli, and Medipol Mega University Hospital. These JCI-accredited facilities offer checkpoint inhibitors and personalized systemic therapies following American and European protocols through multidisciplinary tumor boards and expert medical oncologists.
- Anadolu Medical Center: Affiliated with Johns Hopkins Medicine, using U.S. treatment standards and ESMO-certified specialists.
- Memorial Şişli Hospital: First JCI-accredited hospital in Turkey, known for its high-tech 53,000 square meter facility.
- Medipol Mega Hospital: One of Turkey's largest complexes featuring advanced technologies like the Da Vinci system.
- Liv Hospital Ulus: Ranked by Newsweek, focusing on precision medicine and advanced diagnostic imaging for staging.
Bookimed Expert Insight: Anadolu Medical Center stands out because its specialists, like Prof. Bulent Karagoz, focus specifically on tumor immunology. With over 40 peer-reviewed publications, the team applies Johns Hopkins protocols directly. This academic depth often leads to more precise dosing of expensive immunotherapy drugs compared to general clinics.
Patient Consensus: Patients emphasize the need to verify if specific immunotherapy protocols are EMA-approved. Many recommend coordinating with a home oncologist for long-term follow-up care after returning from Istanbul.
Are there specialized doctors for this procedure in Turkey?
Turkey hosts highly specialized medical oncologists, many of whom are European Society for Medical Oncology (ESMO) certified and trained at prestigious institutions like Johns Hopkins or MD Anderson. These experts operate within JCI-accredited centers in Istanbul, providing advanced immunotherapy protocols and multidisciplinary care for prostate cancer patients.
- Expert credentials: Surgeons like Professor Bulent Karagoz follow Johns Hopkins U.S. clinical protocols in Istanbul.
- International certification: Many specialists hold ESMO Board Certification and memberships in the American Society of Clinical Oncology.
- Clinical research: Leading oncologists, including Nail Paksoy, participate in international clinical trials for immunotherapy.
- Facility standards: Centers like Anadolu Medical Center are OECI-accredited, the gold standard for European cancer institutes.
Bookimed Expert Insight: While immunotherapy is available, it is often utilized as a secondary treatment after hormone therapy or robotic surgery in Turkey. Data shows top-tier clinics like Anadolu Medical Center or Hisar Hospital Intercontinental integrate immunotherapy primarily for advanced stages. Patients seeking these specific drugs benefit most from professors who have 20+ years of experience and dual fellowships in the US or UK.
Patient Consensus: Patients recommend choosing Istanbul-based oncology heads for virtual consultations before traveling. Many suggest confirming drug availability early, as some immunotherapy options are treated as specialized additions to standard surgical care.
























